Home › Companies › REGENXBIO Inc. › 2025-2026

REGENXBIO Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and REGENXBIO Inc.’s Form 8-K, filed June 3, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 7Reported items
  • 178Asset managers
  • 1,502Fund votes
  • May 29, 2026Meeting date

Results at a glance

Meeting of May 29, 2026: 7 items on REGENXBIO Inc.’s Form 8-K, filed June 3, 2026: 3 elected · 3 approved · 1 not approved.

Not approved or not elected

  • 5. A Stock Option Exchange Program for the Company's executive employees 40% of votes cast Not approved Under 80%

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore REGENXBIO Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by REGENXBIO Inc.

These tallies are REGENXBIO Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

REGENXBIO Inc. — official shareholder meeting results, meeting held May 29, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Jean Bennett, M.D., Ph.D. 24,025,836---- 11,238,9267,554,121 68%Elected—
Elect Director: A.N. "Jerry" Karabelas, Ph.D. 27,124,923---- 8,139,8397,554,121 77%Elected—
Elect Director: Daniel Tassé 32,039,753---- 3,225,0097,554,121 91%Elected—
2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 42,526,553244,78547,545 --0 99.4%Approved—
3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement 32,392,3022,722,825149,635 --7,554,121 92%Approved—
4. The Stock Option Exchange Program for the Company's non-executive employees 26,352,4568,853,23059,076 --7,554,121 75%Approved—
5. A Stock Option Exchange Program for the Company's executive employees 14,097,81521,021,531145,416 --7,554,121 40%Not approved—

Source: REGENXBIO Inc., Form 8-K, filed with the SEC on June 3, 2026 — read the filing on EDGAR.

How asset managers voted at the REGENXBIO Inc. 2025-2026 meeting

Each item below shows how the 178 asset managers that disclosed a REGENXBIO Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REGENXBIO Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: A.N. "Jerry" Karabelas, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%WITHHELD
FOR: 27,124,923WITHHELD: 8,139,839
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of three Class II Directors: A.N. "Jerry" Karabelas, Ph.D.

REGENXBIO Inc.’s own tally for this item (“Elect Director: A.N. "Jerry" Karabelas, Ph.D.”): 27,124,923 for, 8,139,839 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company's 2029 annual meeting of stockholders:”
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 12,325,319 for, 417,873 withheld, 19,512 abstained.

FOR
FOR: 12,325,319ABSTAIN: 19,512WITHHOLD: 417,873
Largest asset managers voting on “Election of three Class II Directors: A.N. "Jerry" Karabelas, Ph.D.” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,021,9450 4,0811,921For
JPMorgan2,052,7430 00For
BlackRock2,050,3720 00For
State Street1,559,2420 02,011For
Fidelity1,399,5430 00For
TIAA567,0960 00For
Charles Schwab390,5040 00For
Dimensional00 0342,335Withhold
Columbia Threadneedle196,7840 00For
Delaware/Macquarie149,0000 00For
Equitable67,4900 046,030Mixed
MFS93,3690 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
Brighthouse63,2810 011,499Mixed
Lincoln Financial58,4170 05,071Mixed
AIG/SunAmerica61,8360 00For
Harbor ETF Trust48,4920 00For
Global X44,4430 00For
Russell Investments43,7960 00For
ProShares42,1080 00For
Northern Trust30,7120 00For
ALPS ETF Trust29,2120 00For
MASTER INVESTMENT PORTFOLIO26,8090 00For
Voya25,7790 00For
SEI22,4360 00For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

2. Elect Director: Daniel Tassé

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 9 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 32,039,753WITHHELD: 3,225,009
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of three Class II Directors: Daniel Tasse

REGENXBIO Inc.’s own tally for this item (“Elect Director: Daniel Tassé”): 32,039,753 for, 3,225,009 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company's 2029 annual meeting of stockholders:”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 12,327,311 for, 415,893 withheld, 15,439 abstained.

FOR
FOR: 12,327,311ABSTAIN: 15,439WITHHOLD: 415,893
Largest asset managers voting on “Election of three Class II Directors: Daniel Tasse” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,023,8780 80For
JPMorgan2,052,7430 00For
BlackRock2,050,3720 00For
State Street1,559,3020 01,951For
Fidelity1,399,5430 00For
TIAA567,0960 00For
Charles Schwab390,5040 00For
Dimensional00 0342,335Withhold
Columbia Threadneedle196,7840 00For
Delaware/Macquarie149,0000 00For
Equitable67,4900 046,030Mixed
MFS93,3690 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
Brighthouse63,2810 011,499Mixed
Lincoln Financial58,4170 05,071Mixed
AIG/SunAmerica61,8360 00For
Harbor ETF Trust48,4920 00For
Global X44,4430 00For
Russell Investments43,7960 00For
ProShares42,1080 00For
Northern Trust30,7120 00For
ALPS ETF Trust29,2120 00For
MASTER INVESTMENT PORTFOLIO26,8090 00For
Voya25,7790 00For
SEI22,4360 00For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

3. Elect Director: Jean Bennett, M.D., Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD
FOR: 24,025,836WITHHELD: 11,238,926
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of three Class II Directors: Jean Bennett, M.D., Ph.D.

REGENXBIO Inc.’s own tally for this item (“Elect Director: Jean Bennett, M.D., Ph.D.”): 24,025,836 for, 11,238,926 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company's 2029 annual meeting of stockholders:”
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 11,726,819 for, 1,003,476 withheld, 32,410 abstained.

FOR
FOR: 11,726,819ABSTAIN: 32,410WITHHOLD: 1,003,476
Largest asset managers voting on “Election of three Class II Directors: Jean Bennett, M.D., Ph.D.” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard2,996,8580 4,08927,000For
JPMorgan2,052,7430 00For
BlackRock2,050,3720 00For
State Street1,557,5940 03,659For
Fidelity1,372,1430 027,400For
TIAA567,0960 00For
Charles Schwab390,5040 00For
Dimensional00 0342,335Withhold
Columbia Threadneedle196,7840 00For
Delaware/Macquarie00 0149,000Withhold
Equitable67,4900 046,030Mixed
MFS00 093,369Withhold
QUANTITATIVE MASTER SERIES LLC79,4420 00For
Brighthouse47,8850 026,895Mixed
Lincoln Financial58,4170 05,071Mixed
AIG/SunAmerica00 061,836Withhold
Harbor ETF Trust48,4920 00For
Global X44,4430 00For
Russell Investments43,7960 00For
ProShares00 042,108Withhold
Northern Trust00 030,712Withhold
ALPS ETF Trust00 029,212Withhold
MASTER INVESTMENT PORTFOLIO26,8090 00For
Voya00 025,779Withhold
SEI22,4360 00For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

4. To approve a stock option exchange for our executive employees.

No official matchCOMPENSATION

Combines 2 wordings of this item as funds reported it.

46.3% of fund votes cast · no official result

FORAGAINST
Details: votes by 58 asset managers

The 58 asset managers below reported 5,916,446 for, 6,854,976 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 5,916,446AGAINST: 6,854,976
Largest asset managers voting on “To approve a stock option exchange for our executive employees.” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard2,996,83731,110 00For
JPMorgan2,052,7430 00For
BlackRock02,050,372 00Against
State Street1,1981,560,055 00Against
Fidelity01,399,543 00Against
TIAA0567,096 00Against
Charles Schwab390,5040 00For
Dimensional0342,335 00Against
Columbia Threadneedle196,7840 00For
Delaware/Macquarie0149,000 00Against
Equitable0113,520 00Against
MFS093,369 00Against
QUANTITATIVE MASTER SERIES LLC079,442 00Against
Brighthouse47,88526,895 00Mixed
Lincoln Financial26,31737,171 00Mixed
AIG/SunAmerica061,836 00Against
Harbor ETF Trust48,4920 00For
Global X44,4430 00For
Russell Investments43,7960 00For
ProShares042,108 00Against
Northern Trust030,712 00Against
ALPS ETF Trust029,212 00Against
MASTER INVESTMENT PORTFOLIO026,809 00Against
Voya25,7790 00For
SEI22,4360 00For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

5. 4. The Stock Option Exchange Program for the Company's non-executive employees

Official resultCOMPENSATIONReported outcome: Approved

75% Approved · of votes cast

FOR 75%AGAINST
FOR: 26,352,456AGAINST: 8,853,230
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: To approve a stock option exchange for our non-executive employees.

REGENXBIO Inc.’s own tally for this item (“4. The Stock Option Exchange Program for the Company's non-executive employees”): 26,352,456 for, 8,853,230 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 : By the following vote, the stockholders approved, the Stock Option Exchange Program for the Company's non-executive employees:”
Support: 75% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 9,267,571 for, 3,495,133 against.

FORAGAINST
FOR: 9,267,571AGAINST: 3,495,133
Largest asset managers voting on “To approve a stock option exchange for our non-executive employees.” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard2,996,86431,082 00For
JPMorgan2,052,7430 00For
BlackRock2,050,3720 00For
State Street1,1981,560,055 00Against
Fidelity403,601995,942 00Mixed
TIAA567,0960 00For
Charles Schwab390,5040 00For
Dimensional0342,335 00Against
Columbia Threadneedle196,7840 00For
Delaware/Macquarie0149,000 00Against
Equitable67,49046,030 00Mixed
MFS93,3690 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
Brighthouse47,88526,895 00Mixed
Lincoln Financial26,31737,171 00Mixed
AIG/SunAmerica061,836 00Against
Harbor ETF Trust48,4920 00For
Global X44,4430 00For
Russell Investments43,7960 00For
ProShares042,108 00Against
Northern Trust030,712 00Against
ALPS ETF Trust029,212 00Against
MASTER INVESTMENT PORTFOLIO26,8090 00For
Voya25,7790 00For
SEI22,4360 00For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

6. 3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

92% Approved · of votes cast

FOR 92%
FOR: 32,392,302AGAINST: 2,722,825
Details: description as filed, official tally, votes by 178 asset managers

Description as filed by funds: Advisory vote on the compensation paid to the Company's executive employees.

REGENXBIO Inc.’s own tally for this item (“3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement”): 32,392,302 for, 2,722,825 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 : By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 57 asset managers voting on “Advisory vote on the compensation paid to the Company's executive employees.” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,027,9397 00For
JPMorgan2,052,7430 00For
BlackRock2,050,3720 00For
State Street1,560,609644 00For
Fidelity1,399,5430 00For
TIAA567,0960 00For
Charles Schwab390,5040 00For
Dimensional342,3350 00For
Columbia Threadneedle196,7840 00For
Delaware/Macquarie149,0000 00For
Equitable113,5200 00For
MFS93,3690 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
Brighthouse63,2810 11,4990Mixed
Lincoln Financial63,4880 00For
AIG/SunAmerica61,8360 00For
Harbor ETF Trust48,4920 00For
Global X44,4430 00For
Russell Investments43,7960 00For
ProShares42,1080 00For
Northern Trust30,7120 00For
ALPS ETF Trust29,2120 00For
MASTER INVESTMENT PORTFOLIO26,8090 00For
Voya25,7790 00For
SEI22,4360 00For

Fund voting reports, all 57 managers: 12,749,093 for, 2,113 against, 11,499 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 140 asset managers voting on “Advisory vote on the compensation paid to the Company's executive employees.” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Redmile Group, LLC4,368,8040 00For
State Street2,434,9003,368 00For
BlackRock2,321,87011,543 00For
GEODE CAPITAL MANAGEMENT, LLC1,137,4980 00For
Invesco916,5810 00For
AQR773,1510 00For
Nuveen582,1090 00For
STIFEL NICOLAUS & CO INC \MO\451,0070 00For
Charles Schwab390,6010 00For
Goldman Sachs382,6550 00For
Vanguard334,5940 00For
Integral Health Asset Management, LLC315,7690 00For
Fidelity303,3680 00For
Voss Capital, LP295,7870 00For
ArchPoint Investors215,1970 00For
Kintegral Advisory, LLC201,9810 00For
Northern Trust189,4281,455 00For
DE Shaw151,8570 00For
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST149,0000 00For
Two Sigma145,3490 00For
MELLON INVESTMENTS Corp139,1500 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/130,6530 00For
Renaissance126,7740 00For
JPMorgan106,6520 00For
T. Rowe Price102,2580 00For

Institutional-manager reports, all 140 managers: 17,589,733 for, 181,017 against, 250 abstained. Showing the 25 largest; see all in the interactive database.

7. 2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

99.4% Approved · of votes cast

FOR 99.4%
FOR: 42,526,553AGAINST: 244,785
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026.

REGENXBIO Inc.’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 42,526,553 for, 244,785 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 12,751,145 for, 59 against, 11,499 abstained.

FOR
FOR: 12,751,145AGAINST: 59ABSTAIN: 11,499
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as th” at REGENXBIO Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,027,9450 00For
JPMorgan2,052,7430 00For
BlackRock2,050,3720 00For
State Street1,561,19459 00For
Fidelity1,399,5430 00For
TIAA567,0960 00For
Charles Schwab390,5040 00For
Dimensional342,3350 00For
Columbia Threadneedle196,7840 00For
Delaware/Macquarie149,0000 00For
Equitable113,5200 00For
MFS93,3690 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
Brighthouse63,2810 11,4990Mixed
Lincoln Financial63,4880 00For
AIG/SunAmerica61,8360 00For
Harbor ETF Trust48,4920 00For
Global X44,4430 00For
Russell Investments43,7960 00For
ProShares42,1080 00For
Northern Trust30,7120 00For
ALPS ETF Trust29,2120 00For
MASTER INVESTMENT PORTFOLIO26,8090 00For
Voya25,7790 00For
SEI22,4360 00For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

Largest REGENXBIO Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 51,617,000 shares outstanding at the time of that meeting.

Fund voting reports: top REGENXBIO Inc. shareholders by shares voted on “Advisory vote on the compensation paid to the Company's executive employees.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 5.87%
2JPMorgan 3.98%
3BlackRock 3.97%
4State Street 3.02%
5Fidelity 2.71%
6TIAA 1.10%
7Charles Schwab 0.76%
8Dimensional 0.66%
9Columbia Threadneedle 0.38%
10Delaware/Macquarie 0.29%
Institutional-manager reports: top REGENXBIO Inc. shareholders by shares voted on “Advisory vote on the compensation paid to the Company's executive employees.”, 2025-2026
#Asset manager % of shares outstanding
1Redmile Group, LLC 8.46%
2State Street 4.72%
3BlackRock 4.52%
4GEODE CAPITAL MANAGEMENT, LLC 2.20%
5Invesco 1.78%
6AQR 1.50%
7Nuveen 1.13%
8STIFEL NICOLAUS & CO INC \MO\ 0.87%
9Charles Schwab 0.76%
10Goldman Sachs 0.74%

Reported REGENXBIO Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

REGENXBIO Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 11.20% 13F
Redmile Group, LLC 10.07% DEF14A
JPMorgan Chase 6.75% 13F
Vanguard Group 6.54% 13F
Entities Affiliated with Allan M. Fox Bryn Mawr Trust Company 5.58% DEF14A
State Street 5.29% 13F
Morgan Stanley 3.90% 13F
Goldman Sachs 3.56% 13F
Geode Capital 2.20% 13F
AQR Capital 2.04% 13F

Percentages above are of 51,617,000 shares outstanding, as reported by REGENXBIO Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENXBIO Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At REGENXBIO Inc.'s shareholder meeting held May 29, 2026, in the 2025-2026 proxy season, 178 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,502 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote on the compensation paid to the Company's executive employees. — REGENXBIO Inc.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: REGENXBIO Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2026.

REGENXBIO Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.